Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8AE4

Crystal structure of human legumain in complex with Clitocypin 2

8AE4 の概要
エントリーDOI10.2210/pdb8ae4/pdb
分子名称Legumain, Clitocypin-2, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (5 entities in total)
機能のキーワードcysteine protease, ligase, asparaginyl endopeptidase, aep, inhibitor, exosite, active site, substrate, hydrolase
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数2
化学式量合計49053.69
構造登録者
Elamin, T.,Brandstetter, H.,Dall, E. (登録日: 2022-07-12, 公開日: 2022-09-28, 最終更新日: 2024-01-31)
主引用文献Elamin, T.,Santos, N.P.,Briza, P.,Brandstetter, H.,Dall, E.
Structural and functional studies of legumain-mycocypin complexes revealed a competitive, exosite-regulated mode of interaction.
J.Biol.Chem., 298:102502-102502, 2022
Cited by
PubMed Abstract: Under pathophysiologic conditions such as Alzheimer's disease and cancer, the endolysosomal cysteine protease legumain was found to translocate to the cytosol, the nucleus, and the extracellular space. These noncanonical localizations demand for a tight regulation of legumain activity, which is in part conferred by protein inhibitors. While there is a significant body of knowledge on the interaction of human legumain with endogenous cystatins, only little is known on its regulation by fungal mycocypins. Mycocypins are characterized by (i) versatile, plastic surface loops allowing them to inhibit different classes of enzymes and (ii) a high resistance toward extremes of pH and temperature. These properties make mycocypins attractive starting points for biotechnological and medical applications. In this study, we show that mycocypins utilize an adaptable reactive center loop to target the active site of legumain in a substrate-like manner. The interaction was further stabilized by variable, isoform-specific exosites, converting the substrate recognition into inhibition. Additionally, we found that selected mycocypins were capable of covalent complex formation with legumain by forming a disulfide bond to the active site cysteine. Furthermore, our inhibition studies with other clan CD proteases suggested that mycocypins may serve as broad-spectrum inhibitors of clan CD proteases. Our studies uncovered the potential of mycocypins as a new scaffold for drug development, providing the basis for the design of specific legumain inhibitors.
PubMed: 36116553
DOI: 10.1016/j.jbc.2022.102502
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.79 Å)
構造検証レポート
Validation report summary of 8ae4
検証レポート(詳細版)ダウンロードをダウンロード

248942

件を2026-02-11に公開中

PDB statisticsPDBj update infoContact PDBjnumon